Guidelines for Adult Stroke Rehabilitation and Recovery: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
| Line 140: | Line 140: | ||
|} | |} | ||
===Assessment, Prevention, and Treatment of Hemiplegic Shoulder Pain=== | ===Assessment, Prevention, and Treatment of Hemiplegic Shoulder Pain=== | ||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LightGreen"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''<nowiki>"</nowiki> .''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:A]] )'' <nowiki>"</nowiki> | |||
|- | |||
|} | |||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
|- | |- | ||
| Line 177: | Line 184: | ||
|- | |- | ||
|} | |} | ||
===Central Pain After Stroke=== | ===Central Pain After Stroke=== | ||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
Revision as of 14:21, 13 December 2016
|
Ischemic Stroke Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Guidelines for Adult Stroke Rehabilitation and Recovery On the Web |
|
American Roentgen Ray Society Images of Guidelines for Adult Stroke Rehabilitation and Recovery |
|
FDA on Guidelines for Adult Stroke Rehabilitation and Recovery |
|
CDC on Guidelines for Adult Stroke Rehabilitation and Recovery |
|
Guidelines for Adult Stroke Rehabilitation and Recovery in the news |
|
Blogs on Guidelines for Adult Stroke Rehabilitation and Recovery |
|
Risk calculators and risk factors for Guidelines for Adult Stroke Rehabilitation and Recovery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Guidelines for Adult Stroke Rehabilitation and Recovery
Organization of Poststroke Rehabilitation Care
| Class I |
| "1." It is recommended that stroke patients who are candidates for postacute rehabilitation receive organized, coordinated, interprofessional care(Level of Evidence:A ) " |
| "2." It is recommended that stroke survivors who qualify for and have access to IRF care receive treatment in an IRF in preference to a SNF. (Level of Evidence:B ) " |
| "3." Organized community-based and coordinated interprofessional rehabilitation care is recommended in the outpatient or home-based settings. (Level of Evidence:C ) " |
| Class IIb |
| "1."ESD services may be reasonable for people with mild to moderate disability.(Level of Evidence:B ) " |
Rehabilitation
Interventions in the Inpatient Hospital Setting
| Class I |
| "1." It is recommended that early rehabilitation for hospitalized stroke patients be provided in environments with organized, interprofessional stroke care. (Level of Evidence:A ) " |
| "2." It is recommended that stroke survivors receive rehabilitation at an intensity commensurate with anticipated benefit and tolerance (Level of Evidence:B ) " |
| Class III |
| "1." High-dose, very early mobilization within 24 hours of stroke onset can reduce the odds of a favorable outcome at 3 months and is not recommended.. (Level of Evidence:A ) " |
Prevention of Skin Breakdown and Contractures
| Class I |
| "1." During hospitalization and inpatient rehabilitation, regular skin assessments are recommended with objective scales of risk such as the Braden scale (Level of Evidence:C ) " |
| "2." It is recommended to minimize or eliminate skin friction, to minimize skin pressure, to provide appropriate support surfaces, to avoid excessive moisture, and to maintain adequate nutrition and hydration to prevent skin breakdown. Regular turning, good skin hygiene, and use of specialized mattresses, wheelchair
cushions, and seating are recommended until mobility returns. (Level of Evidence:C ) " |
| "3." Patients, staff, and caregivers should be educated about the prevention of skin breakdown. (Level of Evidence:C ) " |
| Class IIa |
| "1."Positioning of hemiplegic shoulder in maximum external rotation while the patient is either sitting or in bed for 30 minutes daily is probably indicated..(Level of Evidence:B ) " |
| Class IIb |
| "1." Resting hand/wrist splints, along with regular stretching and spasticity management in patients lacking active hand movement, may be considered..(Level of Evidence:C ) " |
| "2." Use of serial casting or static adjustable splints may be considered to reduce mild to moderate elbow and wrist contractures.(Level of Evidence:C ) " |
| "3." Surgical release of brachialis, brachioradialis, and biceps muscles may be considered for substantial elbow contractures and associated pain.(Level of Evidence:B ) " |
| "4." Resting ankle splints used at night and during assisted standing may be considered for prevention of ankle contracture in the hemiplegic limb..(Level of Evidence:B ) " |
Prevention of DVT
| Class I |
| "1." In ischemic stroke, prophylactic-dose subcutaneous heparin (UFH or LMWH) should be used for the duration of the acute and rehabilitation hospital stay or until the stroke survivor regains mobility. (Level of Evidence:A ) " |
| Class IIa |
| "1." In ischemic stroke, it is reasonable to use prophylactic-dose LMWH over prophylactic dose UFH for prevention of DVT.(Level of Evidence:A ) " |
| Class IIb |
| "1." In ischemic stroke, it may be reasonable to use intermittent pneumatic compression over no prophylaxis during the acute hospitalization.(Level of Evidence:B ) " |
| "2." In ICH, it may be reasonable to use prophylactic-dose subcutaneous heparin (UFH or LMWH) started between days 2 and 4 over no prophylaxis..(Level of Evidence:C ) " |
| "3." In ICH, it may be reasonable to use prophylactic dose LMWH over prophylactic-dose UFH.(Level of Evidence:C ) " |
| "4." In ICH, it may be reasonable to use intermittent pneumatic compression devices over no prophylaxis.(Level of Evidence:C ) " |
| Class III |
| "1." In ischemic stroke, it is not useful to use elastic compression stockings. (Level of Evidence:B ) " |
| "2." In ICH, it is not useful to use elastic compression stockings.(Level of Evidence:C ) " |
Treatment of Bowel and Bladder Incontinence
| Class I |
| "1." Assessment of bladder function in acutely hospitalized stroke patients is recommended. A history of urological issues before stroke should be obtained. (Level of Evidence:B ) " |
| "2." Assessment of urinary retention through bladder scanning or intermittent catheterizations after voiding while recording volumes is recommended for patients
with urinary incontinence or retention. (Level of Evidence:B ) |
| "Removal of the Foley catheter (if any) within 24 hours after admission for acute stroke is recommended.(Level of Evidence:B ) |
| Class IIa |
| "1." Assessment of cognitive awareness of need to void or having voided is reasonable.(Level of Evidence:B ) " |
| "2." It is reasonable to use the following treatment interventions to improve bladder incontinence in stroke patients:
a) Prompted voiding b) Pelvic floor muscle training (after discharge home.(Level of Evidence:B ) " |
| Class IIb |
| "1." It may be reasonable to assess prior bowel function in acutely hospitalized stroke patients and include the following.(Level of Evidence:C) "
a) Stool consistency, frequency, and timing (before stroke) b) Bowel care practices before stroke |
Assessment, Prevention, and Treatment of Hemiplegic Shoulder Pain
| Class IIa |
| "1." .(Level of Evidence:A ) " |
| Class IIa |
| "1." .(Level of Evidence:A ) " |
| "2.".(Level of Evidence:C ) " |
| "3.".(Level of Evidence:C ) " |
| "4.".(Level of Evidence:C ) " |
| Class IIb |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:B ) " |
| "5.".(Level of Evidence:B ) " |
| "6.".(Level of Evidence:C ) " |
| Class III |
| "1." . (Level of Evidence:C ) " |
Central Pain After Stroke
| Class I |
| "1." (Level of Evidence:C ) " |
| "2." (Level of Evidence:C ) " |
| Class III |
| "1." . (Level of Evidence:B ) " |
| "2." . (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:C ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:C ) " |
| "3.".(Level of Evidence:B ) " |
Prevention of Falls
| Class I |
| "1." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:B ) " |
| "2." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:A ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
Seizures
| Class I |
| "1." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:C ) " |
| Class III |
| "1." . (Level of Evidence:C ) " |
Poststroke Depression, Including Emotional and Behavioral State
| Class I |
| "1." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:B ) " |
| "2." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:B ) " |
| "3." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:B ) " |
| Class IIb |
| Class IIa |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:C ) " |
| Class IIa |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:A ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:B ) " |
| "5.".(Level of Evidence:B ) " |
| "6.".(Level of Evidence:B ) " |
| Class III |
| "1." . (Level of Evidence:A ) " |
Poststroke Osteoporosis
| Class I |
| "1." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:A ) " |
| "2." Defining TIA with a 24-hour maximum duration has the potential to delay the initiation of effective stroke therapies(Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
Assessment of Disability and Rehabilitation Needs
| Class I |
| "1." (Level of Evidence:B ) " |
| "2." (Level of Evidence:B ) " |
| "3." (Level of Evidence:C ) " |
| "4." (Level of Evidence:C ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:C ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
Assessment of Motor Impairment, Activity, and Mobility
| Class IIa |
| "1.".(Level of Evidence:C ) " |
| "2.".(Level of Evidence:C ) " |
| "3.".(Level of Evidence:C ) " |
| "4.".(Level of Evidence:C ) " |
| "5.".(Level of Evidence:C ) " |
| "6.".(Level of Evidence:C ) " |
| "7.".(Level of Evidence:C ) " |
Assessment of Communication Impairment
| Class I |
| "1." (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:A ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |
Assessment of Cognition and Memory
| Class I |
| "1." (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:C ) " |
Sensory Impairments, Including Touch, Vision, and Hearing
| Class IIa |
| "1.".(Level of Evidence:B ) " |
Dysphagia Screening, Management, and Nutritional Support
| Class I |
| "1." (Level of Evidence:B ) " |
| "2." (Level of Evidence:B ) " |
| "3." (Level of Evidence:B ) " |
| "4." (Level of Evidence:A ) " |
| "5." (Level of Evidence:B ) " |
| "6." (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:C ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:C ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |
| "2.".(Level of Evidence:A ) " |
| "3.".(Level of Evidence:B ) " |
| Class III |
| "1." . (Level of Evidence:A ) " |
Nondrug Therapies for Cognitive Impairment, Including Memory
| Class I |
| "1." (Level of Evidence:A ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |
| "2.".(Level of Evidence:C ) " |
| "3.".(Level of Evidence:A ) " |
| "4.".(Level of Evidence:B ) " |
| "5.".(Level of Evidence:B ) " |
| "6.".(Level of Evidence:B ) " |
Use of Drugs to Improve Cognitive Impairments, Including Attention
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:C ) " |
Limb Apraxia
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:C ) " |
Hemispatial Neglect or Hemi-Inattention
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
Cognitive Communication Disorders
| Class IIa |
| "1.".(Level of Evidence:B ) " |
Aphasia
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:B ) " |
| Class III |
| "1." . (Level of Evidence:B ) " |
Motor Speech Disorders:Dysarthria and Apraxia of Speech
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:A ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |
| "2.".(Level of Evidence:C ) " |
Spasticity
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:A ) " |
| Class IIa |
| "1.".(Level of Evidence:A ) " |
| Class IIb |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:A ) " |
| "3.".(Level of Evidence:A ) " |
| "4.".(Level of Evidence:C ) " |
| Class III |
| "1." . (Level of Evidence:B ) " |
Balance and Ataxia
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:A ) " |
| "3." (Level of Evidence:C ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |
Mobility
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:A ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:B ) " |
| "5.".(Level of Evidence:B ) " |
| "6.".(Level of Evidence:B ) " |
| "7.".(Level of Evidence:B ) " |
| "8.".(Level of Evidence:B ) " |
| "9.".(Level of Evidence:B ) " |
| "10.".(Level of Evidence:A ) " |
| "11.".(Level of Evidence:A ) " |
| "12.".(Level of Evidence:A ) " |
| Class III |
| "1." . (Level of Evidence:B ) " |
Upper Extremity Activity, Including ADLs, IADLs, Touch, and Proprioception
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:A ) " |
| "3." (Level of Evidence:B ) " |
| Class IIa |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:A ) " |
| "3.".(Level of Evidence:A ) " |
| "4.".(Level of Evidence:A ) " |
| "5.".(Level of Evidence:B ) " |
| "6.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:A ) " |
| Class III |
| "1." . (Level of Evidence:A ) " |
Adaptive Equipment, Durable Medical Devices, Orthotics, and Wheelchairs
| Class I |
| "1." (Level of Evidence:B ) " |
| "2." (Level of Evidence:B ) " |
| "3." (Level of Evidence:C ) " |
| "4." (Level of Evidence:C ) " |
Chronic Care Management: Home- and Community-Based Participation
| Class I |
| "1." (Level of Evidence:A ) " |
| "2." (Level of Evidence:A ) " |
Treatments/Interventions for Visual Impairments
| Class I |
| "1." (Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
| "4.".(Level of Evidence:B ) " |
| "5.".(Level of Evidence:B ) " |
| "6.".(Level of Evidence:C ) " |
| "7.".(Level of Evidence:C ) " |
| Class III |
| "1." . (Level of Evidence:B ) " |
Hearing Loss
| Class IIa |
| "1.".(Level of Evidence:C ) " |
| "2.".(Level of Evidence:C ) " |
| "3.".(Level of Evidence:C ) " |
| "4.".(Level of Evidence:C ) " |
Ensuring Medical and Rehabilitation Continuity Through the Rehabilitation Process and Into the Community
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
Social and Family Caregiver Support
| Class IIb |
| "1.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:A ) " |
| "2.".(Level of Evidence:B ) " |
Referral to Community Resources
| Class I |
| "1." (Level of Evidence:C ) " |
| "2." (Level of Evidence:C ) " |
| "3." (Level of Evidence:C ) " |
| "4." (Level of Evidence:C ) " |
| "5." (Level of Evidence:C ) " |
Rehabilitation in the Community
| Class I |
| "1." (Level of Evidence:A ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:B ) " |
Sexual Function
| Class IIb |
| "1.".(Level of Evidence:B ) " |
Recreational and Leisure Activity
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "2.".(Level of Evidence:B ) " |
| "3.".(Level of Evidence:B ) " |
Return to Work
| Class IIa |
| "1.".(Level of Evidence:C ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |
Return to Driving
| Class I |
| "1." (Level of Evidence:C ) " |
| Class IIa |
| "1.".(Level of Evidence:B ) " |
| "1.".(Level of Evidence:B ) " |
| Class IIb |
| "1.".(Level of Evidence:C ) " |